Given the rare incidence of SOT in IBD patients, our large IBD patient cohort enabled us to perform a large single center study (n = 31 SOT cases) on the IBD disease course and anti-TNF-treatment efficacy before and after SOT in a well-characterized IBD cohort. This evidence concerns the gene TNF and inflammatory bowel disease.